相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of 1,3,4-oxidiazole scaffold compounds as inhibitors of superoxide dismutase expression
Thomas J. Lukas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Erythropoietin modulates the immune-inflammatory response of a SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Min Young Noh et al.
NEUROSCIENCE LETTERS (2014)
Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
Shin H. Kang et al.
NATURE NEUROSCIENCE (2013)
Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels
Fernando Bartolome et al.
NEURON (2013)
Treatment of Idiopathic Membranous Nephropathy
Meryl Waldman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis
Chi-Hong Wu et al.
NATURE (2012)
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Elisa Rubino et al.
NEUROLOGY (2012)
Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to Ectopics
Carlotta Pozza et al.
JOURNAL OF ONCOLOGY (2012)
SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Faisal Fecto et al.
ARCHIVES OF NEUROLOGY (2011)
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips et al.
LANCET NEUROLOGY (2011)
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Han-Xiang Deng et al.
NATURE (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
A yeast functional screen predicts new candidate ALS disease genes
Julien Couthouis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present
Mario Rafael Pagani et al.
NEUROLOGY RESEARCH INTERNATIONAL (2011)
Long-term effect of ACTH treatment of relapse in multiple sclerosis
M. C. Hoogstraten et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Role of Asparagine-Linked Glycosylation in Cell Surface Expression and Function of the Human Adrenocorticotropin Receptor (Melanocortin 2 Receptor) in 293/FRT Cells
Simon Roy et al.
ENDOCRINOLOGY (2010)
Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
R. Lee Mosley et al.
EXPERIMENTAL NEUROLOGY (2010)
ACTH is a potent regulator of gene expression in human adrenal cells
Yewei Xing et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosis
Matthis Synofzik et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Mutations of optineurin in amyotrophic lateral sclerosis
Hirofumi Maruyama et al.
NATURE (2010)
Bio-equivalence of IM and SQ HP Acthar® Gel
Staley Armstrong Brod et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Age and founder effect of SOD1 A4V mutation causing ALS
M. Saeed et al.
NEUROLOGY (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi et al.
NATURE GENETICS (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling
Min Chen et al.
BIOCHEMISTRY (2007)
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes
J. C. Schymick et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Michael Benatar
NEUROBIOLOGY OF DISEASE (2007)
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
N. Parkinson et al.
NEUROLOGY (2006)
Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria
HX Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
MJ Greenway et al.
NATURE GENETICS (2006)
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Piera Pasinelli et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Early-onset ALS with long-term survival associated with spastin gene mutation
T Meyer et al.
NEUROLOGY (2005)
Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis
P Weydt et al.
NEUROREPORT (2005)
Increased persistent Na+ current and its effect on excitability in motoneurones cultured from mutant SOD1 mice
JJ Kuo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
AL Nishimura et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis
F Gros-Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis
I Niebroj-Dobosz et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis
Y Yang et al.
NATURE GENETICS (2001)
A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C
KM Noh et al.
NEUROBIOLOGY OF DISEASE (2000)